Diabetes Care, Vol 21, Issue 9 1540-1544, Copyright © 1998 by American Diabetes Association
Association of NIDDM and hearing loss
DS Dalton, KJ Cruickshanks, R Klein, BE Klein and TL Wiley
Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison 53705-2397, USA. dalton@epi.ophth.wisc.edu
OBJECTIVE: To evaluate the association of NIDDM with hearing loss in a
large population-based study. RESEARCH DESIGN AND METHODS: Data from
population-based longitudinal studies of aging conducted in Beaver Dam,
Wisconsin, were used in these analyses. Hearing thresholds were determined
by pure-tone air- and bone-conduction audiometry performed by trained
technicians following American Speech-Language-Hearing Association
specifications. Hearing loss was defined as the pure-tone average of the
frequencies 500, 1,000, 2,000, and 4,000 Hz greater than 25 decibels
hearing level in the worse ear. Diabetes status was determined by
self-report of physician-diagnosed diabetes or by elevated glucose or
glycated hemoglobin levels at examination. RESULTS: Of 3,571 study
participants, 344 were classified as having NIDDM. Subjects with NIDDM were
more likely to have a hearing loss than were subjects without diabetes (59
vs. 44%). After results were adjusted for age, this difference was not
statistically significant. After individuals with hearing loss patterns
inconsistent with presbycusis were excluded, there was an association
between NIDDM and hearing loss when controlling for potential confounders
(odds ratio [OR] 1.41, 95% CI 1.05-1.88). There was no association between
duration of diabetes or glycemic control and hearing loss. Individuals with
NIDDM and nephropathy were more likely to have a hearing loss than were
those with NIDDM but no nephropathy (OR 2.28, 95% CI 1.04-5.00).
CONCLUSIONS: These data are suggestive of a weak association between NIDDM
and hearing loss.